Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 609
can-a-previous-abortion-or-miscarriage-influence-a-woman’s-breast-cancer-risk?
Posted inBiotechnology

Can a Previous Abortion or Miscarriage Influence a Woman’s Breast Cancer Risk?

February 11, 2026
A comprehensive nationwide study originating from Finland has delivered critical insights into the longstanding debate concerning abortion, miscarriage, and breast…
Read More
how-do-certain-factors-influence-life-expectancy-in-individuals-with-spina-bifida?
Posted inBiotechnology

How Do Certain Factors Influence Life Expectancy in Individuals with Spina Bifida?

February 11, 2026
Groundbreaking Research Unveils Life Expectancy Variations in Open Spina Bifida Patients Open spina bifida, a congenital neural tube defect characterized…
Read More
‘when-the-markets-opened,-we-were-ready’:-why-biotech-ipos-are-back-for-2026
Posted inBiotechnology

‘When the markets opened, we were ready’: Why biotech IPOs are back for 2026

February 11, 2026
Whisper it, but we may finally be seeing the IPO window reopening in 2026. Biotech listings saw their heyday in…
Read More
transition-dynamics-in-older-adults-receiving-home-care
Posted inBiotechnology

Transition Dynamics in Older Adults Receiving Home Care

February 11, 2026
A groundbreaking study has emerged, shedding light on the complexities of health transitions among older adults who are availing themselves…
Read More
madrigal-pens-$4.4b-deal-for-ribo’s-preclinical-sirna-programs-in-latest-rezdiffra-mash-play
Posted inBiotechnology

Madrigal pens $4.4B deal for Ribo’s preclinical siRNA programs in latest Rezdiffra MASH play

February 11, 2026
Madrigal Pharmaceuticals is continuing to splash the cash this year on liver disease drugs it can combine with its own…
Read More
new-study-reveals-routine-aspirin-therapy-reduces-severe-preeclampsia-risk-in-vulnerable-pregnancies
Posted inBiotechnology

New Study Reveals Routine Aspirin Therapy Reduces Severe Preeclampsia Risk in Vulnerable Pregnancies

February 11, 2026
Embargoed until 10:15 AM PST, February 11, 2026 In a groundbreaking development within obstetric medicine, a new observational study presented…
Read More
upstream-posts-tezspire-like-asthma-efficacy-in-phase-2-but-falls-short-of-best-case-scenario
Posted inBiotechnology

Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario

February 11, 2026
A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But, with only the 12-week…
Read More
nonablative-radiofrequency-shows-promise-in-enhancing-sexual-function-among-postmenopausal-women
Posted inBiotechnology

Nonablative Radiofrequency Shows Promise in Enhancing Sexual Function Among Postmenopausal Women

February 11, 2026
In the evolving landscape of menopause management, novel nonhormonal therapeutic strategies are gaining remarkable attention as alternatives to traditional hormone…
Read More
struggling-with-chemistry-at-school?-it’s-not-entirely-the-subject’s-fault
Posted inBiotechnology

Struggling with Chemistry at School? It’s Not Entirely the Subject’s Fault

February 11, 2026
In today’s educational landscape, chemistry is often met with trepidation and disengagement among students. This widespread aversion, known academically as…
Read More
introducing-dayu3d:-a-cutting-edge-tool-for-thermal-hydraulic-design-and-accident-analysis-in-htgrs
Posted inBiotechnology

Introducing DAYU3D: A Cutting-Edge Tool for Thermal-Hydraulic Design and Accident Analysis in HTGRs

February 11, 2026
Advancements in high-temperature gas-cooled reactors (HTGRs) are revolutionizing the future of nuclear energy systems. These reactors are increasingly recognized for…
Read More

Posts pagination

Previous page 1 … 607 608 609 610 611 … 827 Next page

Privacy Policy    Terms

Scroll to Top